MR imaging of tumor angiogenesis using sterically stabilized Gd-DTPA liposomes targeted to CD105

European Journal of Radiology

Volumn 70, Issue 1, 2009, Pages 180-189

  Zhang, Dong ^a   Feng, Xiao Yuan ^b   Henning, Tobias D ^c   Wen, Li ^a   Lu, Wei Yue ^d   Pan, Hong ^d   Wu, Xing ^b   Zou, Li Guang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Department of Pharmaceutical Targeting   (China)

Author keywords

Angiogenesis; CD105; Gd DTPA; MRI; Sterically stabilized liposomes; Tumor

Indexed keywords

ANGIOGENESIS; CD105; GD-DTPA; MRI; STERICALLY STABILIZED LIPOSOMES;

BEARINGS (STRUCTURAL); BLOOD VESSELS; FLUORESCENCE; LIPOSOMES; PHOSPHOLIPIDS; RATS; TUMORS;

GADOLINIUM;

ENDOGLIN; IMMUNOGLOBULIN; LIPOSOME; PENTETIC ACID GADOLINIUM; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; GLIOMA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; CONTRAST MEDIA; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GADOLINIUM DTPA; GLIOMA; LIPOSOMES; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED F344; RECEPTORS, CELL SURFACE; TUMOR MARKERS, BIOLOGICAL;

EID: 63649105680     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.04.022     Document Type: Article

References (54)

1. Feigin I., Allen L., and Gross S.W. The endothelium hyperplasia of the cerebral blood vessels with brain tumors and its sarcomatous transformation. Cancer 11 2 (1958) 264-277
2. Kuster B., Leenders W.P.J., Weesseling P., et al. Vascular endothelial growth factor-A165 induces progression of melanoma brain metastases without induction of sprouting angiogenesis. Cancer Res 62 2 (2002) 341-345
3. Leenders W.P.J., Kusters B., and Waal R.M.W. Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis. Endothelium 9 2 (2002) 83-88
4. Holash J., Maisonpierre P.C., Compton D., et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284 5422 (1999) 1994-1998
5. Li C., Gardy R., Seon B.K., et al. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Br J Cancer 88 9 (2003) 1424-1431
6. Rubenstein J.L., Kim J., Ozawa T., et al. Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2 4 (2000) 306-314
7. Kunkel P., Ulbricht U., Bohlen P., et al. Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclone antibody against vascular endothelial growth factor-2. Cancer Res 61 18 (2001) 6624-6628
8. Gupta K., Radotra B.D., Banerjee A.K., and Nijhawan R. Quantitation of angiogenesis and its correlation with vascular endothelial growth factor expression in astrocytic tumors. Anal Quant Cytol Histol 26 4 (2004) 223-229
9. Behrem S., Zarkovic K., Eskinja N., and Jonjic N. CD105 is a better marker than CD31 in evaluation of angiogenesis in glioblastoma. Croat Med J 46 3 (2005) 417-422
10. Anderson S.A., Rader R.K., Westlin W.F., et al. Magnetic resonance contrast enhancement of neovasculature with αvβ3-targeted nanoparticles. Magn Reson Med 44 3 (2000) 433-439
11. Cai W., Gambhir S.S., and Chen X. Multimodality tumor imaging targeting integrin αvβ3. Biotechniques 39 (2005) S6-S17
12. Aronen H.J., Gazit I.E., Louis D.N., et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histological findings. Radiology 191 1 (1994) 41-51
13. Brash R., Pham C., Shames D., et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 7 1 (1997) 68-74
14. Kassner A., Annesley D., Zhu X.P., et al. Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast enhanced imaging: a possible marker of vascular tortuosity. J Magn Reson Imaging 11 2 (2000) 103-113
15. Dennie J., Mandeville J.B., Boxerman J.L., et al. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 40 6 (1998) 793-799
16. Jensen J.H., and Chandra R. MR imaging of microvasculature. Magn Reson Med 44 2 (2000) 224-230
17. Abramovitch R., Frenkiel D., and Neeman M. Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn Reson Med 39 5 (1998) 813-824
18. Griffiths J.R., Taylor N.J., Howe F.A., et al. The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging. Int J Radiat Oncol Biol Phys 39 3 (1997) 697-701
19. Abramovitch R., Dafni H., Smouha E., et al. In vivo prediction of vascular susceptibility to vascular endothelial growth factor withdrawal: magnetic resonance of C6 rat glioma in nude mice. Cancer Res 59 19 (1999) 5012-5016
20. Hunjan S., Mason R.P., Constantinescu A., et al. Regional tumor oximetry: 19F NMR spectroscopy of hexafluorobenzene. Int J Radiat Oncol Biol Phys 41 1 (1998) 161-171
21. Mason R.P., Hunjan S., Le D., et al. Regional tumor oxygen tension: fluorine echo planar imaging of hexafluorobenzene reveals heterogeneity of dynamics. Int J Radiat Oncol Biol Phys 42 4 (1998) 747-750
22. Romani A.A., Borghetti A.F., Del Rio P., Sianesi M., and Soliani P. The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count. J Surg Oncol 93 6 (2006) 446-455
23. Yao Y., Kubota T., Takeuchi H., and Sato K. prognostic significance of a microvessel density determined by an anti-CD105/CD105 monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 mococlonal antibody. Neuropathology 25 3 (2005) 201-206
24. Charpin C., Dales J.P., Garcia S., et al. Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays. Clin Cancer Res 10 17 (2004) 5815-5819
25. Allen T.M., Brandeis E., Hansen C.B., Kao G.Y., and Zalipsky S. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim Biophys Acta 1237 2 (1995) 99-108
26. Blume G., Cevc G., Crommelin M.D., Bakker-Woudenberg I.A., Kluft C., and Storm G. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim Biophys Acta 1149 1 (1993) 180-184
27. Maruyama K., Takizaua T., Yuda T., Kennel S.J., Huang L., and Iwatsuru M. Targetability of novel immunoliposome modified with amphipathic poly (ethylene glycol) conjugated at their distal terminals to monoclonal antibodies. Biochim Biophys Acta 1234 1 (1995) 74-80
28. Tilcock C., Unger E., Cullis P., and MacDougall P. Liposomal Gd-DTPA: preparation and characterization of relaxivity. Radiology 171 1 (1989) 77-80
29. Mrsny R.J., Volwerk J.J., and Griffith O.H. A simplified procedure for lipid phosphorus analysis shows that digestion rates vary with phospholipids structure. Chem Phys Lipids 39 1-2 (1986) 185-191
30. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147 1 (1995) 9-19
31. Folkman J. Clinical application of research on angiogenesis. N Engl J Med 333 26 (1995) 1757-1763
32. Ellis L.M., and Fidler I.J. Angiogenesis and metastasis. Eur J Cancer 32A 14 (1996) 2451-2460
33. Fox S.B., Gasparini G., and Harris A.L. Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. Lancet Oncol 2 5 (2001) 278-289
34. Weidner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 184 2 (1998) 119-122
35. McDonald D.M., and Choyke P.L. Imaging of angiogenesis: from microscope to clinic. Nat Med 9 6 (2003) 713-725
36. Weissleder R., and Mahmood U. Molecular imaging. Radiology 219 2 (2001) 316-333
37. Winter P.M., Caruthers S.D., Kassner C.A., et al. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel αvβ3-targeted nanoparticle and 1.5T magnetic resonance imaging. Cancer Res 63 18 (2003) 5838-5843
38. Sipkins D.A., Cheresh D.A., Kazemi M.R., et al. Detection of tumor angiogenesis in vivo by alpha v beta3-targeted magnetic resonance imaging. Nat Med 4 5 (1998) 623-626
39. Anderson S.A., Rader R.K., Weatlin W.F., et al. Magnetic resonance contrast enhancement of neovasculature withαvβ3-targeted nanoparticles. Magn Reson Med 44 3 (2000) 433-439
40. Mulder W.J., Strijkers G.J., Habets J.W., et al. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 19 14 (2005) 2008-2010
41. Janssen M.L., Oyen W.J., Dijkgraaf I., et al. Tumor targeting with radiolabeled αvβ3 integrin binding peptides in a nude mouse model. Cancer Res 62 21 (2002) 6146-6151
42. Sadeghi M.M., Krassilnikova S., Zhang J., et al. Detection of injury-induced vascular remodeling by targeting activated αvβ3 integrin in vivo. Circulation 110 1 (2004) 84-90
43. Ogawa M., Hatano K., Oishi S., et al. Direct electrophilic radiofluorination of a cyclic RGD peptide for in vivo αvβ3 integrin related tumor imaging. Nucl Med Biol 30 1 (2003) 1-9
44. Montet X., Ntziachristos V., Grimm J., and Weissleder R. Tomographic fluorescence mapping of tumor targets. Cancer Res 65 14 (2005) 6330-6336
45. Chen X., Conti P.S., and Moats R.A. In vivo near-infrared fluorescence imaging of integrin αvβ3 in brain tumor xenografts. Cancer Res 64 21 (2004) 8009-8014
46. Ellegala D.B., Leong-Poi H., Carpenter J.E., et al. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation 108 3 (2003) 336-341
47. Leong-Poi H., Christiansen J., Klibanov A.L., Kaul S., and Lindner J.R. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation 107 3 (2003) 455-460
48. Massoud T.F., and Gambhir S.S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17 5 (2003) 545-580
49. Wu N.Z., Da D., Rudoll T.L., Needham D., Whorton A.R., and Dewhirst M.W. Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res 53 16 (1993) 3765-3770
50. Needham D., McIntosh T.J., and Lasic D.D. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim Biophys Acta 1108 1 (1992) 40-48
51. Maruyama K., Takahashi N., Tagawa T., Nagaike K., and Iwatsuru M. Immunoliposomes bearing polyethyleneglycol-coupled Fab′ fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo. FEBS Lett 413 1 (1997) 177-180
52. Park Y.S. Tumor-directed targeting of liposomes. Biosci Rep 22 2 (2002) 267-281
53. Mastrobattista E., Koning G.A., and Storm G. Immunoliposomes for the targeted delivery of antitumor drugs. Adv Drug Deliv Rev 40 1-2 (1999) 103-127
54. Unger E.C., MacDougall P., Cullis P., and Tilcock C. Liposomal Gd-DTPA: Effect of encapsulation on enhancement of hepatoma model by MRI. Magn Reson Imaging 7 4 (1989) 417-423